Abstract
During the last few years, high throughput RNA profiling technologies have become nearly indispensable tools in biomedical research. Optimization strategies for the different technologies and bioinformatics tools to mine the wealth of data have developed rapidly to meet the researchers need calling for more sophisticated clinical and pharmaceutical applications and a more integrated view of the cells primary molecules DNA, RNAs and proteins. Integrative network analyses based on quantitative expression data, and the integration of data gained from genome analysis defining the relationships between the cells transcriptome and proteome, are becoming the focus of current research. Key issues to resolve include method developments to optimize analysis of small amounts of tissue or cells and low-abundance messages, and minimize biological noise. DNA microarray technology, oligonucleotide-based microarrays in particular, holds much promise, but may still be largely unexploited. In the wake of experience gathered during expression profiling of human prostate tumors, tissues from human infectious disease models and experimental rodent systems, we discuss here a number of novel DNA microarray-based approaches that may be used in the near future to conduct hypothesis-driven transcriptome research aiming at quantitative models of genetic networks and at narrowing the gap between the transcriptome and the proteome. Such research may also establish microarray technology as indispensable for clinical research near the patients bedside.
Keywords: dna microarrays, quantitative transcriptome, biological networks, rna amplification, disease markers, methylation changes, non-coding rnas
Current Genomics
Title: DNA Microarrays: Perspectives for Hypothesis-Driven Transcriptome Research and for Clinical Applications
Volume: 4 Issue: 6
Author(s): M. Hergenhahn, K. Muhlemann, M. Hollstein and M. Kenzelmann
Affiliation:
Keywords: dna microarrays, quantitative transcriptome, biological networks, rna amplification, disease markers, methylation changes, non-coding rnas
Abstract: During the last few years, high throughput RNA profiling technologies have become nearly indispensable tools in biomedical research. Optimization strategies for the different technologies and bioinformatics tools to mine the wealth of data have developed rapidly to meet the researchers need calling for more sophisticated clinical and pharmaceutical applications and a more integrated view of the cells primary molecules DNA, RNAs and proteins. Integrative network analyses based on quantitative expression data, and the integration of data gained from genome analysis defining the relationships between the cells transcriptome and proteome, are becoming the focus of current research. Key issues to resolve include method developments to optimize analysis of small amounts of tissue or cells and low-abundance messages, and minimize biological noise. DNA microarray technology, oligonucleotide-based microarrays in particular, holds much promise, but may still be largely unexploited. In the wake of experience gathered during expression profiling of human prostate tumors, tissues from human infectious disease models and experimental rodent systems, we discuss here a number of novel DNA microarray-based approaches that may be used in the near future to conduct hypothesis-driven transcriptome research aiming at quantitative models of genetic networks and at narrowing the gap between the transcriptome and the proteome. Such research may also establish microarray technology as indispensable for clinical research near the patients bedside.
Export Options
About this article
Cite this article as:
Hergenhahn M., Muhlemann K., Hollstein M. and Kenzelmann M., DNA Microarrays: Perspectives for Hypothesis-Driven Transcriptome Research and for Clinical Applications, Current Genomics 2003; 4 (6) . https://dx.doi.org/10.2174/1389202033490231
DOI https://dx.doi.org/10.2174/1389202033490231 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting the Immune Niche within the Bone Marrow Microenvironment: The Rise of Immunotherapy in Multiple Myeloma
Current Cancer Drug Targets Irreversible LSD1 Inhibitors: Application of Tranylcypromine and Its Derivatives in Cancer Treatment
Current Topics in Medicinal Chemistry Molecular Diagnosis in Autoimmune Skin Blistering Conditions
Current Molecular Medicine Intractable Cancers: The Many Faces of Multidrug Resistance and the Many Targets it Presents for Therapeutic Attack
Current Drug Targets Marine Derived Bioactive Compounds for Breast and Prostate Cancer Treatment: A Review
Current Bioactive Compounds 2-Arylbenzimidazoles as Antiviral and Antiproliferative Agents-Part 2
Medicinal Chemistry The Role of 18 kDa Mitochondrial Translocator Protein (TSPO) in Programmed Cell Death, and Effects of Steroids on TSPO Expression
Current Molecular Medicine Aflibercept: A Novel VEGF Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Tumors
Mini-Reviews in Medicinal Chemistry Nanoparticle Drug Delivery Systems: Recent Patents and Applications in Nanomedicine
Recent Patents on Nanomedicine Modulating Mesenchymal Stromal Cell Function with Cholesterol Synthesis Inhibitors
Current Medicinal Chemistry Current Dendrimer Applications in Cancer Diagnosis and Therapy
Current Topics in Medicinal Chemistry HIV-1 Reactivation Induced by Apicidin Involves Histone Modification in Latently Infected Cells
Current HIV Research The Quinoline Imidoselenocarbamate EI201 Blocks the AKT/mTOR Pathway and Targets Cancer Stem Cells Leading to a Strong Antitumor Activity
Current Medicinal Chemistry Contemporary Treatment of Amyloid Heart Disease
Current Pharmaceutical Design Identification and Targeting of Tumor Escape Mechanisms: A New Hope for Cancer Therapy?
Current Pharmaceutical Design NF-κB Activation by FcεRI-Mediated Signal Transduction
Current Immunology Reviews (Discontinued) Targeting Endothelial Progenitor Cells in Cancer as a Novel Biomarker and Anti-Angiogenic Therapy
Current Stem Cell Research & Therapy Role of IL-10 in the Resolution of Airway Inflammation
Current Molecular Medicine LHON: Mitochondrial Mutations and More
Current Genomics Versatile and Valuable Utilization of Amidohydrolase L-glutaminase in Pharma and Food industries: A Review
Current Drug Metabolism